SEARCH

SEARCH BY CITATION

References

  • 1
    Selkoe, D.J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23 A31.
  • 2
    Glenner, G.G. & Wong, C.W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 883 890.
  • 3
    Esch, F., Keim, P.S., Beattie, E.C., Blacher, R.W., Culwell, A.R. (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248, 1122 1128.
  • 4
    Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L., Lieberburg, I., Koo, E.H., Schenk, D., Teplow, D.B., Selkoe, D.J. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322 325.
  • 5
    Roher, A.E., Palmer, K.C., Surewicz, E.C., Ball, M.J., Greenberg, B.D. (1993) Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. J. Neurochem. 61, 1916 1926.
  • 6
    Kirschner, D.A., Abraham, C., Selkoe, D.J. (1986) X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer's disease indicates cross-β conformation. Proc. Natl Acad. Sci. USA 83, 503 507.
  • 7
    Jarrett, J.T. & Lansbury, P.T. (1993) Seeding one-dimensional crystallization of amyloid: a pathogenic mechanism in Alzheimer's disease and Scrapie? Cell 73, 1055 1058.
  • 8
    Lomakin, A., Chung, D.S., Benedek, G.B., Kirschner, D.A., Teplow, D.B. (1996) On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl Acad. Sci. USA 93, 1125 1129.
  • 9
    Fraser, P.E., Nguyen, J.T., Chin, D.T., Kirschner, D.A. (1992) Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril–proteoglycan interactions. J. Neurochem. 59, 1531 1540.
  • 10
    Brunden, K.R., Richter-Cook, N.J., Chaturvedi, N., Frederickson, R.C.A. (1993) pH-dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J. Neurochem. 61, 2147 2154.
  • 11
    Evans, K.C., Berger, E.P., Cho, C.-G., Weisgraber, K.H., Lansbury, P.T. Jr (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl Acad. Sci. USA 92, 763 767.
  • 12
    Huang, T.H.J., Fraser, P.E., Chakrabartty, A. (1997) Fibrillogenesis of Alzheimer Aß Peptides studied by fluorescence energy transfer. J. Mol. Biol. 269, 214 224.
  • 13
    Castillo, G.M., Ngo, C., Cummings, J., Wight, T.N., Snow, A.D. (1997) Perlecan binds to the beta-amyloid proteins (Abeta) of Alzheimer's disease, accelerates Abeta fibril formation, and maintains A beta fibril stability. J. Neurochem. 69, 2452 2465.
  • 14
    McLaurin, J., Franklin, T., Zhang, X., Deng, J., Fraser, P.E. (1999) Interactions of Aβ peptides with glycosaminoglycans: effects on fibril nucleation and growth. Eur. J. Biochem. 266, 1101 1110.
  • 15
    Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J., Wight, T.N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456 463.
  • 16
    Su, J.H., Cummings, B.J., Cotman, W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51, 801 813.
  • 17
    Snow, A.D., Nochlin, D., Sekiguchi, R., Carlson, S.S. (1996) Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease. Exp. Neurol. 138, 305 317.
  • 18
    Snow, A.D., Mar, H., Nochlin, D., Kresse, H., Wight, T.N. (1992) Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J. Histochem. Cytochem. 40, 105 113.
  • 19
    Dewitt, D.A., Silver, J., Canning, D.R., Perry, G. (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp. Neurol. 121, 149 152.
  • 20
    Gupta-Bansal, R., Frederickson, R.C.A., Brunden, K.R. (1995) Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J. Biol. Chem. 270, 18666 18671.
  • 21
    Castillo, G.M., Lukito, W., Wight, T.N., Snow, A.D. (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. J. Neurochem. 72, 1681 1687.
  • 22
    Pollack, S.J., Sadler, I.I.J., Hawtin, S.R., Tailor, V.J., Shearman, M.S. (1995) Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC-12 cells. Neurosci. Lett. 184, 113 116.
  • 23
    Fraser, P.E., Nguyen, J.T., Surewicz, W.K., Kirschner, D.A. (1992) pH-dependent structural transitions of Alzheimer β/A4 peptides. Biophys. J. 60, 1190 1201.
  • 24
    Cardin, A.D. & Weintaub, H.J.R. (1989) Molecular modeling of protein–glycosaminoglycan interactions. Arteriosclerosis 9, 21 32.
  • 25
    Kisilevsky, R. (1989) Theme and variations on a string of amyloid. Neurobiol. Aging 10, 499 500.
  • 26
    Jao, S., Ma, K., Talafous, J., Orlando, R., Zagorski, M.G. (1997) Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid beta-peptide. Amyloid: Int. J. Exp. Clin. Invest. 4, 240 252.
  • 27
    Barrow, C.J. & Zagorski, M.G. (1991) Solution structure of beta peptide and its constituent fragments: relation to amyloid deposits. Science 253, 179 182.
  • 28
    Talafous, J.K., Marcinowski, J., Klopman, G., Zagorski, M.G. (1994) Solution structure of residues 1–28 of the amyloid beta-peptide. Biochemistry 33, 7788 7796.
  • 29
    Kirshenbaum, K. & Daggett, V. (1995) pH-dependent conformations of the amyloid beta (1–28) peptide fragments explored using molecular dynamics. Biochemistry 34, 7629 7639.
  • 30
    Fraser, P.E., McLachlan, D.R., Surewicz, W.K., Mizzen, C.A., Snow, A.D., Nguyen, J.T., Kirschner, D.A. (1994) Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitution of charged residues. J. Mol. Biol. 244, 64 73.
  • 31
    Kirschner, D.A., Inouye, H., Duffy, L.K., Sinclair, A., Lind, M., Selkoe, D.J. (1987) Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid-like fibres in vitro. Proc. Natl Acad. Sci. USA 84, 6953 6957.
  • 32
    Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L., Beyreuther, K. (1992) Aggregation and Secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 218, 149 163.
  • 33
    Sipe, J. (1992) Amyloidosis. Annu. Rev. Biochem. 61, 947 975.
  • 34
    Sunde, M., Serpell, L.C., Bartlam, M., Fraser, P.E., Pepys, M.B., Blake, C.C.F. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273, 729 793.
  • 35
    Watson, D.J., Lander, A.D., Selkoe, D.J. (1997) Heparin-binding properties of the amyloidogenic peptides Aβ and amylin. J. Biol. Chem. 272, 31617 31624.
  • 36
    Castillo, G.M., Cummings, J.A., Yang, W., Judge, M.E., Sheardown, M.J., Rimwall, K., Hansen, J.B., Snow, A.D. (1998) Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes 47, 612 620.
  • 37
    Jiang, X., Myatt, E., Lykos, P., Stevens, F.J. (1997) Interaction between glycosaminoglycans and immunoglobulin light chains. Biochemistry 36, 13187 13194.
  • 38
    Iwasaki, W., Hatanaka, H., Inui, T., Kimura, T., Muramatsu, T., Yoshida, K., Tasumi, M., Inagaki, F. (1997) Solution structure of midkine, a new heparin-binding growth factor. EMBO 16, 6936 6946.
  • 39
    Seno, M., Sasada, R., Kurokawa, T., Igarashi, K. (1990) Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparin. Eur. J. Biochem. 188, 239 245.
  • 40
    Seddon, A., Decker, M., Muller, T., Armellino, D., Kovesdi, I., Gluzman, Y., Bohlen, P. (1991) Structure/activity relationships in basic FGF. Ann. NY Acad. Sci. 638, 98 108.
  • 41
    Coltrini, D., Rusnati, M., Zoppetti, G., Oreste, P., Isacchi, A., Caccia, P., Bergonzoni, L., Presta, M. (1993) Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies. Eur. J. Biochem. 214, 51 58.
  • 42
    Thompson, L.D., Pantoliano, M.W., Springer. B.A. (1994) Energetic characterization of the basic growth factor–heparin interaction: identification of the heparin binding domain. Biochemistry 33, 3831 3840.
  • 43
    Olson, S.T. & Bjork, I. (1991) Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin–thrombin reaction. Elucidation from salt concentration effects. J. Biol. Chem. 266, 6353 6364.
  • 44
    Scott, J.E., Chen, Y., Brass, A. (1992) Secondary and tertiary structures involving chondroitin and chondroitin sulphates in solution, investigated by rotary shadowing/electron microscopy and computer simulation. Eur. J. Biochem. 209, 675 680.
  • 45
    Giulian, D., Haverkamp, L.J., Yu, J., Karshin, W., Tom, D., Li, J., Kazanskaia, A., Kirkpatrick, J., Roher, A.E. (1998) The HHQK domain of β-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J. Biol. Chem. 273, 29719 29726.